Ranbaxy Laboratories Ltd
May 28, 2012 at 11:26 | Source: Moneycontrol.com
May 23, 2012 at 15:00 | Source: CNBC-TV18
May 17, 2012 at 15:38 | Source: Moneycontrol.com
May 17, 2012 at 10:12 | Source: Reuters
May 15, 2012 at 15:05 | Source: Moneycontrol.com
May 11, 2012 at 15:50 | Source: CNBC-TV18
News across the web »
May 25, 2012 at 09:31 | Source: Economic Times
May 09, 2012 at 12:47 | Source: Economic Times
May 09, 2012 at 12:11 | Source: Economic Times
Apr 25, 2012 at 16:11 | Source: The Hindu BusinessLine
Apr 20, 2012 at 12:51 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
Janssen Pharmaceuticals Inc., sued Germany-based Haupt Pharma AG's U.S. unit, Haupt Pharma Inc., as well as India-based Ranbaxy Laboratories Ltd. and its New Jersey-based unit, Ranbaxy Laboratories Inc. Janssen alleges the generics makers filed abbreviated ...
May 23, 2012 at 17:10 | Source: site.law360.com
Ltd (NSE: GAIL), Ranbaxy Laboratories Ltd (NSE: RANBAXY) and Infrastructure Development Finance Company Ltd (NSE: IDFC). On sectoral front almost all the sectoral indices closed in red barring IT and Pharma sector closed marginally in green. Major selling ...
May 23, 2012 at 10:58 | Source: Commodity Online
... technology companies Infosys Ltd. and Tata Consultancy Services Ltd., and pharma companies like Lupin Ltd. and Ranbaxy Laboratories Ltd. Their foreign earnings are worth more in rupees now, but given the speed with which the rupee has lost ...
May 25, 2012 at 09:30 | Source: Wall Street Journal
Four Indian drug makers get US nod to launch generic version of Plavix 19-MAY-12 Four Indian drug makers — Dr Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries ... in the last three straight weeks. Ranbaxy surges on robust Q1 earnings 09-MAY ...
May 27, 2012 at 06:57 | Source: Business Standard
and Punjab National Bank Ltd (NSE: PNB) while key gainers were Ranbaxy Laboratories Ltd (NSE: RANBAXY), Asian Paints Ltd (NSE: ASIANPAINT) and Bharat Petroleum Corporation Ltd (NSE: BPCL). On sectoral front major selling was seen in Oil & Gas ...
May 14, 2012 at 10:54 | Source: Commodity Online
U.S. patent protection on the drug ended on Nov. 30. Watson Pharmaceuticals Inc. makes the authorized generic version in the U.S., and India's Ranbaxy Laboratories Ltd. is selling the only other approved version of the drug. Mylan and other ...
May 27, 2012 at 10:25 | Source: Yahoo Finance
Inc., National Healthcare Systems Co., Ltd., Health Care Service Corporation, Amgen Inc., Genzyme Corporation, Pfizer Inc., AstraZeneca PLC, MetLife, Inc., Novartis AG, Pfizer Inc., Ranbaxy Laboratories Limited, Sanofi-Aventis, West Penn ...
May 27, 2012 at 09:06 | Source: Yahoo Finance
Ranbaxy Laboratories plans to re-launch in the US its former skincare brand Sotret that was banned for almost four years, via a marketing partnership with a Canadian firm Cipher Pharmaceuticals Ltd, reports Economic Times. Before the ban in 2008 ...
May 21, 2012 at 02:32 | Source: Livemint.com
Copies of the medicine sold by local drug makers, including Natco, Cipla, Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd, are available at Rs9,000-11,000 for a month’s therapy. “It (Glivec) has about 15,000 patients, almost half of ...
May 8, 2012 at 18:04 | Source: Livemint.com
Stocks in news: Reliance Industries Ltd is planning to roll out its 4G network in ... The stock is down about half a percent. Ranbaxy Laboratories plans to re-launch its former flagship skincare brand Sotret in the US through a marketing pact ...
May 21, 2012 at 03:44 | Source: firstpost.com